GRAP2

UniProt ID: O75791
Organism: Homo sapiens
Review Status: COMPLETE
πŸ“ Provide Detailed Feedback

Gene Description

GRAP2 (GADS, also called GrpL, Grf40, Mona) is a hematopoietic-restricted cytosolic adaptor of the GRB2 family with no catalytic activity. It has an N-terminal SH3 domain, a central SH2 domain, a unique ~120-residue glutamine/proline-rich linker and a C-terminal SH3 domain. The C-terminal SH3 domain binds an atypical, non-PxxP R-x-x-K motif in the scaffold SLP-76 (LCP2) with nanomolar affinity, so GADS and SLP-76 form a constitutive complex. After antigen-receptor engagement, the GADS SH2 domain docks on ZAP70/SYK-phosphorylated LAT (pY171 and pY191 in the conventional short-isoform numbering; pY200 and pY220 in canonical LAT O43561-1), recruiting SLP-76 to the LAT signalosome at the plasma membrane, where SLP-76 assembles PLCG1, ITK, VAV1 and NCK. GADS thereby couples the T cell receptor to PLCG1 phosphorylation, calcium flux and NFAT activation, sets the sensitivity of T cells to weak TCR stimuli, and acts the same way downstream of FcERI in mast cells and of GPVI/CLEC-2 in platelets (where it is partly redundant with GRB2). Its activity is tuned by dimerization, ITK phosphorylation of Y45, phosphorylation of T262 and caspase cleavage of the linker. The C-terminal SH3 domain also binds HPK1 (MAP4K1), and the SH2 domain binds phosphorylated SHC, KIT, the M-CSF receptor, LAX1 and CD6. GADS-deficient mice have impaired thymocyte proliferation and selection and severely impaired IgE-mediated mast cell activation.

Existing Annotations Review

GO Term Evidence Action Reason
GO:0001784 phosphotyrosine residue binding
IBA
GO_REF:0000033
ACCEPT
Summary: IBA phosphotyrosine residue binding (GRB2-family node).
Reason: The GADS SH2 domain binds phosphotyrosine motifs (pY-x-N-x) on LAT, LAX, SHC and receptor tyrosine kinases; crystal structures and calorimetry show selective binding to LAT pY171/pY191 (short-isoform numbering; pY200/pY220 in canonical LAT O43561-1). Inherited GRB2-family SH2 activity, correctly placed.
Supporting Evidence:
PMID:15029250
Gads-SH2 binds LAT tyrosine phosphorylation sites 171 and 191 with higher affinities than the other sites
PMID:10021361
this interaction was mediated by the Gads SH2 domain
GO:0005515 protein binding
IPI
PMID:12359715
Molecular cloning of a novel gene encoding a membrane-associ...
MODIFY
Summary: IPI protein binding with the transmembrane adaptor LAX1 (PMID:12359715).
Reason: LAX, like LAT, is tyrosine-phosphorylated after antigen-receptor stimulation and then binds GADS; this is the GADS SH2 domain recognising phosphotyrosine motifs. Replace protein binding with phosphotyrosine residue binding (abstract-only paper; the abstract states the tyrosine-motif basis).
Proposed replacements: phosphotyrosine residue binding
Supporting Evidence:
PMID:12359715
LAX has tyrosine motifs for binding Grb2, Gads, and the p85 subunit of phosphatidylinositol 3-kinase
GO:0005515 protein binding
IPI
PMID:15929943
Novel Src homology 3 domain-binding motifs identified from p...
REMOVE
Summary: IPI protein binding with LCP2 (SLP-76) from a SH3-domain peptide-array screen of the SLP-76 proline-rich region (PMID:15929943).
Reason: Generic protein binding from a high-throughput or screening assay; it carries no functional information and the paper does not establish a specific GRAP2 activity with this partner. The GADS-SLP-76 interaction itself is well established and is captured by signaling adaptor activity on the mechanistic rows (PMID:17235283, PMID:17010654, PMID:20534575).
GO:0005515 protein binding
IPI
PMID:16189514
Towards a proteome-scale map of the human protein-protein in...
REMOVE
Summary: IPI protein binding with STAMBP from a CCSB-HI1 yeast two-hybrid screen (PMID:16189514).
Reason: Generic protein binding from a high-throughput or screening assay; it carries no functional information and the paper does not establish a specific GRAP2 activity with this partner.
GO:0005515 protein binding
IPI
PMID:16189514
Towards a proteome-scale map of the human protein-protein in...
REMOVE
Summary: IPI protein binding with LCP2 (SLP-76) from a CCSB-HI1 yeast two-hybrid screen (PMID:16189514).
Reason: Generic protein binding from a high-throughput or screening assay; it carries no functional information and the paper does not establish a specific GRAP2 activity with this partner. The GADS-SLP-76 interaction itself is well established and is captured by signaling adaptor activity on the mechanistic rows (PMID:17235283, PMID:17010654, PMID:20534575).
GO:0005515 protein binding
IPI
PMID:16273093
A quantitative protein interaction network for the ErbB rece...
MODIFY
Summary: IPI protein binding with ERBB2 from a protein-microarray screen of SH2/PTB domains against ErbB phosphopeptides (PMID:16273093).
Reason: The assay measured binding of isolated SH2 domains to ErbB phosphotyrosine peptides, so the informative activity captured is phosphotyrosine residue binding by the GADS SH2 domain. ERBB2 is not a physiological GADS partner in leukocytes; the replacement records only the domain activity.
Proposed replacements: phosphotyrosine residue binding
Supporting Evidence:
PMID:16273093
we use protein microarrays comprising virtually every Src homology 2 (SH2) and phosphotyrosine binding (PTB) domain encoded in the human genome
GO:0005515 protein binding
IPI
PMID:16730941
A systematic analysis of human CHMP protein interactions: ad...
REMOVE
Summary: IPI protein binding with STAMBP from a CHMP interaction screen (PMID:16730941).
Reason: Generic protein binding from a high-throughput or screening assay; it carries no functional information and the paper does not establish a specific GRAP2 activity with this partner.
GO:0005515 protein binding
IPI
PMID:17010654
Crystal structure of the C-terminal SH3 domain of the adapto...
MODIFY
Summary: IPI protein binding with SLP-76 (LCP2) from PMID:17010654, a mechanistic study of the GADS C-terminal SH3 domain / SLP-76 RxxK interaction.
Reason: The interaction is real and central to GRAP2 function, but "protein binding" is uninformative. The C-SH3 of GADS constitutively binds the SLP-76 RxxK motif and its SH2 binds phospho-LAT, so the physiological activity is bridging SLP-76 to LAT, i.e. signaling adaptor activity (the same MF used for LCP2 in this project).
Proposed replacements: signaling adaptor activity
Supporting Evidence:
PMID:17010654
Following T cell receptor ligation, GADS interacts through its C-terminal SH3 domain with the adaptors SLP-76 and LAT, to form a multiprotein signaling complex that is crucial for T cell activation
PMID:10021361
Gads may promote cross-talk between the LAT and SLP-76 signaling complexes, thereby coupling membrane-proximal events to downstream signaling pathways
GO:0005515 protein binding
IPI
PMID:17065230
A noncanonical SH3 domain binding motif links BK channels to...
REMOVE
Summary: IPI protein binding with mouse Kcnma1 from a BK channel SH3-binding screen (PMID:17065230).
Reason: Generic protein binding from a high-throughput or screening assay; it carries no functional information and the paper does not establish a specific GRAP2 activity with this partner.
GO:0005515 protein binding
IPI
PMID:17235283
Efficient T-cell receptor signaling requires a high-affinity...
MODIFY
Summary: IPI protein binding with SLP-76 (LCP2) from PMID:17235283, a mechanistic study of the GADS C-terminal SH3 domain / SLP-76 RxxK interaction.
Reason: The interaction is real and central to GRAP2 function, but "protein binding" is uninformative. The C-SH3 of GADS constitutively binds the SLP-76 RxxK motif and its SH2 binds phospho-LAT, so the physiological activity is bridging SLP-76 to LAT, i.e. signaling adaptor activity (the same MF used for LCP2 in this project).
Proposed replacements: signaling adaptor activity
Supporting Evidence:
PMID:17235283
In signaling from the T-cell receptor (TCR), the Gads C-terminal SH3 domain binds a core RxxK sequence motif in the SLP-76 scaffold
PMID:17235283
Gads, on the other hand, links phosphorylated LAT to the scaffold protein, SLP-76, which binds the Gads C-SH3 domain
PMID:10021361
Gads may promote cross-talk between the LAT and SLP-76 signaling complexes, thereby coupling membrane-proximal events to downstream signaling pathways
GO:0005515 protein binding
IPI
PMID:20534575
SH2 domain containing leukocyte phosphoprotein of 76-kDa (SL...
MODIFY
Summary: IPI protein binding with SLP-76 (LCP2) from PMID:20534575, a mechanistic study of the GADS C-terminal SH3 domain / SLP-76 RxxK interaction.
Reason: The interaction is real and central to GRAP2 function, but "protein binding" is uninformative. The C-SH3 of GADS constitutively binds the SLP-76 RxxK motif and its SH2 binds phospho-LAT, so the physiological activity is bridging SLP-76 to LAT, i.e. signaling adaptor activity (the same MF used for LCP2 in this project).
Proposed replacements: signaling adaptor activity
Supporting Evidence:
PMID:20534575
ZAP-70 phosphorylation of LAT that is followed by LAT recruitment of the GADS-SLP-76 complex
PMID:10021361
Gads may promote cross-talk between the LAT and SLP-76 signaling complexes, thereby coupling membrane-proximal events to downstream signaling pathways
GO:0005515 protein binding
IPI
PMID:21179510
Histidine domain-protein tyrosine phosphatase interacts with...
REMOVE
Summary: IPI protein binding with PTPN23 (HD-PTP) by yeast two-hybrid, GST pulldown and co-immunoprecipitation (PMID:21179510).
Reason: The GrpL C-terminal SH3 domain binds the histidine domain of HD-PTP in overexpression and in vitro assays, but no physiological function of the interaction for GRAP2 has been shown and no informative MF term follows from it. Removing the generic protein binding row does not dispute the interaction.
Supporting Evidence:
PMID:21179510
another to the C-terminal SH3 domain (amino acid residues 254–330) of Grb2-related protein of the lymphoid system (GrpL)
GO:0005515 protein binding
IPI
PMID:21516116
Next-generation sequencing to generate interactome datasets.
REMOVE
Summary: IPI protein binding with LCP2 (SLP-76) from a Stitch-seq yeast two-hybrid screen (PMID:21516116).
Reason: Generic protein binding from a high-throughput or screening assay; it carries no functional information and the paper does not establish a specific GRAP2 activity with this partner. The GADS-SLP-76 interaction itself is well established and is captured by signaling adaptor activity on the mechanistic rows (PMID:17235283, PMID:17010654, PMID:20534575).
GO:0005515 protein binding
IPI
PMID:24658140
The mammalian-membrane two-hybrid assay (MaMTH) for probing ...
REMOVE
Summary: IPI protein binding with EGFR from a MaMTH membrane two-hybrid screen (PMID:24658140).
Reason: Generic protein binding from a high-throughput or screening assay; it carries no functional information and the paper does not establish a specific GRAP2 activity with this partner.
GO:0005515 protein binding
IPI
PMID:24728074
Enhanced prediction of Src homology 2 (SH2) domain binding p...
MODIFY
Summary: IPI protein binding with KIT from a fluorescence-polarization SH2-domain / phosphopeptide interactome (PMID:24728074).
Reason: The assay measured GRAP2 SH2-domain binding to tyrosine-phosphorylated peptides (e.g. KIT pY703/pY936), so the informative activity is phosphotyrosine residue binding. KIT binding by the GADS SH2 domain is also reported independently (PMID:9872323).
Proposed replacements: phosphotyrosine residue binding
Supporting Evidence:
PMID:24728074
Peptides derived from Tyr(P)-703 and Tyr(P)-936 were the predicted GRB2/GRAP2-binding sites based on motif prediction software
PMID:9872323
The binding specificity of the Gads SH2 domain is similar to Grb2 and mediates the interaction of Gads with Shc, Bcr-Abl and c-kit
GO:0005515 protein binding
IPI
PMID:24728074
Enhanced prediction of Src homology 2 (SH2) domain binding p...
MODIFY
Summary: IPI protein binding with GAB1 from a fluorescence-polarization SH2-domain / phosphopeptide interactome (PMID:24728074).
Reason: The assay measured GRAP2 SH2-domain binding to tyrosine-phosphorylated peptides (e.g. KIT pY703/pY936), so the informative activity is phosphotyrosine residue binding. KIT binding by the GADS SH2 domain is also reported independently (PMID:9872323).
Proposed replacements: phosphotyrosine residue binding
Supporting Evidence:
PMID:24728074
Peptides derived from Tyr(P)-703 and Tyr(P)-936 were the predicted GRB2/GRAP2-binding sites based on motif prediction software
PMID:9872323
The binding specificity of the Gads SH2 domain is similar to Grb2 and mediates the interaction of Gads with Shc, Bcr-Abl and c-kit
GO:0005515 protein binding
IPI
PMID:25036101
Identification of SH3 domain proteins interacting with the c...
REMOVE
Summary: IPI protein binding with ADAM10 from a SH3-domain pulldown screen of the ADAM10 tail (PMID:25036101).
Reason: Generic protein binding from a high-throughput or screening assay; it carries no functional information and the paper does not establish a specific GRAP2 activity with this partner.
GO:0005515 protein binding
IPI
PMID:25241761
Using an in situ proximity ligation assay to systematically ...
REMOVE
Summary: IPI protein binding with ERBB2 from a proximity-ligation survey in HeLa cells (PMID:25241761).
Reason: Generic protein binding from a high-throughput or screening assay; it carries no functional information and the paper does not establish a specific GRAP2 activity with this partner.
GO:0005515 protein binding
IPI
PMID:25416956
A proteome-scale map of the human interactome network.
REMOVE
Summary: IPI protein binding with SPRY2 from a HI-II-14 yeast two-hybrid screen (PMID:25416956).
Reason: Generic protein binding from a high-throughput or screening assay; it carries no functional information and the paper does not establish a specific GRAP2 activity with this partner.
GO:0005515 protein binding
IPI
PMID:25416956
A proteome-scale map of the human interactome network.
REMOVE
Summary: IPI protein binding with LCP2 (SLP-76) from a HI-II-14 yeast two-hybrid screen (PMID:25416956).
Reason: Generic protein binding from a high-throughput or screening assay; it carries no functional information and the paper does not establish a specific GRAP2 activity with this partner. The GADS-SLP-76 interaction itself is well established and is captured by signaling adaptor activity on the mechanistic rows (PMID:17235283, PMID:17010654, PMID:20534575).
GO:0005515 protein binding
IPI
PMID:25814554
Phospho-tyrosine dependent protein-protein interaction netwo...
REMOVE
Summary: IPI protein binding with GAREM1 from a phosphotyrosine-dependent yeast two-hybrid screen (PMID:25814554).
Reason: Generic protein binding from a high-throughput or screening assay; it carries no functional information and the paper does not establish a specific GRAP2 activity with this partner.
GO:0005515 protein binding
IPI
PMID:27107012
Pooled-matrix protein interaction screens using Barcode Fusi...
REMOVE
Summary: IPI protein binding with LCP2 (SLP-76) from a Barcode Fusion Genetics yeast two-hybrid screen (PMID:27107012).
Reason: Generic protein binding from a high-throughput or screening assay; it carries no functional information and the paper does not establish a specific GRAP2 activity with this partner. The GADS-SLP-76 interaction itself is well established and is captured by signaling adaptor activity on the mechanistic rows (PMID:17235283, PMID:17010654, PMID:20534575).
GO:0005515 protein binding
IPI
PMID:27107012
Pooled-matrix protein interaction screens using Barcode Fusi...
REMOVE
Summary: IPI protein binding with LNX1 from a Barcode Fusion Genetics yeast two-hybrid screen (PMID:27107012).
Reason: Generic protein binding from a high-throughput or screening assay; it carries no functional information and the paper does not establish a specific GRAP2 activity with this partner.
GO:0005515 protein binding
IPI
PMID:28514442
Architecture of the human interactome defines protein commun...
REMOVE
Summary: IPI protein binding with STAMBP from a BioPlex affinity-purification mass spectrometry (PMID:28514442).
Reason: Generic protein binding from a high-throughput or screening assay; it carries no functional information and the paper does not establish a specific GRAP2 activity with this partner.
GO:0005515 protein binding
IPI
PMID:28514442
Architecture of the human interactome defines protein commun...
REMOVE
Summary: IPI protein binding with PTPN23 (HD-PTP) from a BioPlex affinity-purification mass spectrometry (PMID:28514442).
Reason: Generic protein binding from a high-throughput or screening assay; it carries no functional information and the paper does not establish a specific GRAP2 activity with this partner.
GO:0005515 protein binding
IPI
PMID:28514442
Architecture of the human interactome defines protein commun...
REMOVE
Summary: IPI protein binding with ZSCAN21 from a BioPlex affinity-purification mass spectrometry (PMID:28514442).
Reason: Generic protein binding from a high-throughput or screening assay; it carries no functional information and the paper does not establish a specific GRAP2 activity with this partner.
GO:0005515 protein binding
IPI
PMID:29997244
LuTHy: a double-readout bioluminescence-based two-hybrid tec...
REMOVE
Summary: IPI protein binding with LCP2 (SLP-76) from a LuTHy two-hybrid benchmark (PMID:29997244).
Reason: Generic protein binding from a high-throughput or screening assay; it carries no functional information and the paper does not establish a specific GRAP2 activity with this partner. The GADS-SLP-76 interaction itself is well established and is captured by signaling adaptor activity on the mechanistic rows (PMID:17235283, PMID:17010654, PMID:20534575).
GO:0005515 protein binding
IPI
PMID:31467278
Maximizing binary interactome mapping with a minimal number ...
REMOVE
Summary: IPI protein binding with LCP2 (SLP-76) from a binary interactome assay benchmark (PMID:31467278).
Reason: Generic protein binding from a high-throughput or screening assay; it carries no functional information and the paper does not establish a specific GRAP2 activity with this partner. The GADS-SLP-76 interaction itself is well established and is captured by signaling adaptor activity on the mechanistic rows (PMID:17235283, PMID:17010654, PMID:20534575).
GO:0005515 protein binding
IPI
PMID:31515488
Extensive disruption of protein interactions by genetic vari...
REMOVE
Summary: IPI protein binding with STAMBP from a variant interaction-perturbation screen (PMID:31515488).
Reason: Generic protein binding from a high-throughput or screening assay; it carries no functional information and the paper does not establish a specific GRAP2 activity with this partner.
GO:0005515 protein binding
IPI
PMID:31980649
Extensive rewiring of the EGFR network in colorectal cancer ...
REMOVE
Summary: IPI protein binding with EGFR from a EGFR-network AP-MS in colorectal cancer cells (PMID:31980649).
Reason: Generic protein binding from a high-throughput or screening assay; it carries no functional information and the paper does not establish a specific GRAP2 activity with this partner.
GO:0005515 protein binding
IPI
PMID:32296183
A reference map of the human binary protein interactome.
REMOVE
Summary: IPI protein binding with MOS from a HuRI yeast two-hybrid reference interactome (PMID:32296183).
Reason: Generic protein binding from a high-throughput or screening assay; it carries no functional information and the paper does not establish a specific GRAP2 activity with this partner.
GO:0005515 protein binding
IPI
PMID:32296183
A reference map of the human binary protein interactome.
REMOVE
Summary: IPI protein binding with PRR35 from a HuRI yeast two-hybrid reference interactome (PMID:32296183).
Reason: Generic protein binding from a high-throughput or screening assay; it carries no functional information and the paper does not establish a specific GRAP2 activity with this partner.
GO:0005515 protein binding
IPI
PMID:32296183
A reference map of the human binary protein interactome.
REMOVE
Summary: IPI protein binding with ZNF250 from a HuRI yeast two-hybrid reference interactome (PMID:32296183).
Reason: Generic protein binding from a high-throughput or screening assay; it carries no functional information and the paper does not establish a specific GRAP2 activity with this partner.
GO:0005515 protein binding
IPI
PMID:32296183
A reference map of the human binary protein interactome.
REMOVE
Summary: IPI protein binding with PBLD from a HuRI yeast two-hybrid reference interactome (PMID:32296183).
Reason: Generic protein binding from a high-throughput or screening assay; it carries no functional information and the paper does not establish a specific GRAP2 activity with this partner.
GO:0005515 protein binding
IPI
PMID:32296183
A reference map of the human binary protein interactome.
REMOVE
Summary: IPI protein binding with PRKAA2 from a HuRI yeast two-hybrid reference interactome (PMID:32296183).
Reason: Generic protein binding from a high-throughput or screening assay; it carries no functional information and the paper does not establish a specific GRAP2 activity with this partner.
GO:0005515 protein binding
IPI
PMID:32296183
A reference map of the human binary protein interactome.
REMOVE
Summary: IPI protein binding with LCP2 (SLP-76) from a HuRI yeast two-hybrid reference interactome (PMID:32296183).
Reason: Generic protein binding from a high-throughput or screening assay; it carries no functional information and the paper does not establish a specific GRAP2 activity with this partner. The GADS-SLP-76 interaction itself is well established and is captured by signaling adaptor activity on the mechanistic rows (PMID:17235283, PMID:17010654, PMID:20534575).
GO:0005515 protein binding
IPI
PMID:32296183
A reference map of the human binary protein interactome.
REMOVE
Summary: IPI protein binding with KPRP from a HuRI yeast two-hybrid reference interactome (PMID:32296183).
Reason: Generic protein binding from a high-throughput or screening assay; it carries no functional information and the paper does not establish a specific GRAP2 activity with this partner.
GO:0005515 protein binding
IPI
PMID:32296183
A reference map of the human binary protein interactome.
REMOVE
Summary: IPI protein binding with Q7Z783 (uncharacterized) from a HuRI yeast two-hybrid reference interactome (PMID:32296183).
Reason: Generic protein binding from a high-throughput or screening assay; it carries no functional information and the paper does not establish a specific GRAP2 activity with this partner.
GO:0005515 protein binding
IPI
PMID:32296183
A reference map of the human binary protein interactome.
REMOVE
Summary: IPI protein binding with RAVER1 from a HuRI yeast two-hybrid reference interactome (PMID:32296183).
Reason: Generic protein binding from a high-throughput or screening assay; it carries no functional information and the paper does not establish a specific GRAP2 activity with this partner.
GO:0005515 protein binding
IPI
PMID:32296183
A reference map of the human binary protein interactome.
REMOVE
Summary: IPI protein binding with GAREM1 from a HuRI yeast two-hybrid reference interactome (PMID:32296183).
Reason: Generic protein binding from a high-throughput or screening assay; it carries no functional information and the paper does not establish a specific GRAP2 activity with this partner.
GO:0005515 protein binding
IPI
PMID:32296183
A reference map of the human binary protein interactome.
REMOVE
Summary: IPI protein binding with SH2D4A from a HuRI yeast two-hybrid reference interactome (PMID:32296183).
Reason: Generic protein binding from a high-throughput or screening assay; it carries no functional information and the paper does not establish a specific GRAP2 activity with this partner.
GO:0005515 protein binding
IPI
PMID:32296183
A reference map of the human binary protein interactome.
REMOVE
Summary: IPI protein binding with ZNF319 from a HuRI yeast two-hybrid reference interactome (PMID:32296183).
Reason: Generic protein binding from a high-throughput or screening assay; it carries no functional information and the paper does not establish a specific GRAP2 activity with this partner.
GO:0005515 protein binding
IPI
PMID:32296183
A reference map of the human binary protein interactome.
REMOVE
Summary: IPI protein binding with GAB2 from a HuRI yeast two-hybrid reference interactome (PMID:32296183).
Reason: Generic protein binding from a high-throughput or screening assay; it carries no functional information and the paper does not establish a specific GRAP2 activity with this partner.
GO:0005515 protein binding
IPI
PMID:32296183
A reference map of the human binary protein interactome.
REMOVE
Summary: IPI protein binding with ZSCAN21 from a HuRI yeast two-hybrid reference interactome (PMID:32296183).
Reason: Generic protein binding from a high-throughput or screening assay; it carries no functional information and the paper does not establish a specific GRAP2 activity with this partner.
GO:0005515 protein binding
IPI
PMID:32814053
Interactome Mapping Provides a Network of Neurodegenerative ...
REMOVE
Summary: IPI protein binding with LCP2 (SLP-76) from a neurodegeneration yeast two-hybrid interactome (PMID:32814053).
Reason: Generic protein binding from a high-throughput or screening assay; it carries no functional information and the paper does not establish a specific GRAP2 activity with this partner. The GADS-SLP-76 interaction itself is well established and is captured by signaling adaptor activity on the mechanistic rows (PMID:17235283, PMID:17010654, PMID:20534575).
GO:0005515 protein binding
IPI
PMID:33961781
Dual proteome-scale networks reveal cell-specific remodeling...
REMOVE
Summary: IPI protein binding with STAMBP from a BioPlex 3.0 AP-MS (PMID:33961781).
Reason: Generic protein binding from a high-throughput or screening assay; it carries no functional information and the paper does not establish a specific GRAP2 activity with this partner.
GO:0005515 protein binding
IPI
PMID:33961781
Dual proteome-scale networks reveal cell-specific remodeling...
REMOVE
Summary: IPI protein binding with GAB1 from a BioPlex 3.0 AP-MS (PMID:33961781).
Reason: Generic protein binding from a high-throughput or screening assay; it carries no functional information and the paper does not establish a specific GRAP2 activity with this partner.
GO:0005515 protein binding
IPI
PMID:33961781
Dual proteome-scale networks reveal cell-specific remodeling...
REMOVE
Summary: IPI protein binding with PTPN23 (HD-PTP) from a BioPlex 3.0 AP-MS (PMID:33961781).
Reason: Generic protein binding from a high-throughput or screening assay; it carries no functional information and the paper does not establish a specific GRAP2 activity with this partner.
GO:0005515 protein binding
IPI
PMID:33961781
Dual proteome-scale networks reveal cell-specific remodeling...
REMOVE
Summary: IPI protein binding with GAREM1 from a BioPlex 3.0 AP-MS (PMID:33961781).
Reason: Generic protein binding from a high-throughput or screening assay; it carries no functional information and the paper does not establish a specific GRAP2 activity with this partner.
GO:0005515 protein binding
IPI
PMID:33961781
Dual proteome-scale networks reveal cell-specific remodeling...
REMOVE
Summary: IPI protein binding with GAB2 from a BioPlex 3.0 AP-MS (PMID:33961781).
Reason: Generic protein binding from a high-throughput or screening assay; it carries no functional information and the paper does not establish a specific GRAP2 activity with this partner.
GO:0005515 protein binding
IPI
PMID:33961781
Dual proteome-scale networks reveal cell-specific remodeling...
REMOVE
Summary: IPI protein binding with ZSCAN21 from a BioPlex 3.0 AP-MS (PMID:33961781).
Reason: Generic protein binding from a high-throughput or screening assay; it carries no functional information and the paper does not establish a specific GRAP2 activity with this partner.
GO:0005515 protein binding
IPI
PMID:37398436
AI-guided pipeline for protein-protein interaction drug disc...
REMOVE
Summary: IPI protein binding with LCP2 (SLP-76) from a PPI-drug-discovery pipeline benchmark set (PMID:37398436).
Reason: Generic protein binding from a high-throughput or screening assay; it carries no functional information and the paper does not establish a specific GRAP2 activity with this partner. The GADS-SLP-76 interaction itself is well established and is captured by signaling adaptor activity on the mechanistic rows (PMID:17235283, PMID:17010654, PMID:20534575).
GO:0005634 nucleus
IDA
PMID:21179510
Histidine domain-protein tyrosine phosphatase interacts with...
KEEP AS NON CORE
Summary: IDA nucleus (PMID:21179510).
Reason: GrpL was seen dispersed through the cytosol and nucleus when overexpressed in HEK293T cells (PMID:21179510); there is no evidence that GADS acts in the nucleus, and its function is at the plasma membrane with phospho-LAT. Retained as an observed, non-core location.
Supporting Evidence:
PMID:21179510
the rest was dispersed throughout the cytosol and in the nucleus
GO:0005634 nucleus
IEA
GO_REF:0000044
KEEP AS NON CORE
Summary: IEA nucleus (GO_REF:0000044).
Reason: GrpL was seen dispersed through the cytosol and nucleus when overexpressed in HEK293T cells (PMID:21179510); there is no evidence that GADS acts in the nucleus, and its function is at the plasma membrane with phospho-LAT. Retained as an observed, non-core location.
Supporting Evidence:
PMID:21179510
the rest was dispersed throughout the cytosol and in the nucleus
GO:0005654 nucleoplasm
IBA
GO_REF:0000033
KEEP AS NON CORE
Summary: IBA is_active_in nucleoplasm (GRB2-family node).
Reason: GRB2-family node inference; a nuclear pool of GADS is observed (overexpression imaging, PMID:21179510; Human Protein Atlas), but no nuclear function is known and its adaptor activity is exercised at phospho-LAT in the plasma membrane. Kept as a non-core location.
GO:0005654 nucleoplasm
IDA
GO_REF:0000052
KEEP AS NON CORE
Summary: IDA nucleoplasm from Human Protein Atlas immunofluorescence (GO_REF:0000052).
Reason: Consistent with the nuclear pool seen in overexpression (PMID:21179510); an observed location without a known function.
GO:0005737 cytoplasm
IBA
GO_REF:0000033
ACCEPT
Summary: IBA cytoplasm (GO_REF:0000033).
Reason: GADS is a soluble cytoplasmic adaptor that is constitutively bound to SLP-76 in the cytosol and recruited to phospho-LAT at the membrane after receptor stimulation.
Supporting Evidence:
PMID:21179510
the rest was dispersed throughout the cytosol and in the nucleus
PMID:10021361
Gads may promote cross-talk between the LAT and SLP-76 signaling complexes, thereby coupling membrane-proximal events to downstream signaling pathways
GO:0005737 cytoplasm
IDA
PMID:21179510
Histidine domain-protein tyrosine phosphatase interacts with...
ACCEPT
Summary: IDA cytoplasm (PMID:21179510).
Reason: GADS is a soluble cytoplasmic adaptor that is constitutively bound to SLP-76 in the cytosol and recruited to phospho-LAT at the membrane after receptor stimulation.
Supporting Evidence:
PMID:21179510
the rest was dispersed throughout the cytosol and in the nucleus
PMID:10021361
Gads may promote cross-talk between the LAT and SLP-76 signaling complexes, thereby coupling membrane-proximal events to downstream signaling pathways
GO:0005737 cytoplasm
IEA
GO_REF:0000044
ACCEPT
Summary: IEA cytoplasm (GO_REF:0000044).
Reason: GADS is a soluble cytoplasmic adaptor that is constitutively bound to SLP-76 in the cytosol and recruited to phospho-LAT at the membrane after receptor stimulation.
Supporting Evidence:
PMID:21179510
the rest was dispersed throughout the cytosol and in the nucleus
PMID:10021361
Gads may promote cross-talk between the LAT and SLP-76 signaling complexes, thereby coupling membrane-proximal events to downstream signaling pathways
GO:0005737 cytoplasm
TAS
PMID:9878555
Molecular cloning and expression of human grap-2, a novel le...
ACCEPT
Summary: TAS cytoplasm (PMID:9878555).
Reason: GADS is a soluble cytoplasmic adaptor that is constitutively bound to SLP-76 in the cytosol and recruited to phospho-LAT at the membrane after receptor stimulation.
Supporting Evidence:
PMID:9878555
The SH2- and SH3-containing adaptor molecules serve to recruit cytosolic signal-transducing molecules to the activated receptor tyrosine kinases
GO:0005768 endosome
IDA
PMID:21179510
Histidine domain-protein tyrosine phosphatase interacts with...
KEEP AS NON CORE
Summary: IDA endosome (PMID:21179510).
Reason: GrpL relocated to endosomes only when co-expressed with HD-PTP constructs carrying the endosome-targeting V-domain; endogenous GADS has not been shown to act on endosomes. Kept as a non-core, partner-dependent location.
Supporting Evidence:
PMID:21179510
led to the relocation of most of the cytosolic Grb2 and GrpL to endosomes
GO:0005768 endosome
IEA
GO_REF:0000044
KEEP AS NON CORE
Summary: IEA endosome (GO_REF:0000044).
Reason: GrpL relocated to endosomes only when co-expressed with HD-PTP constructs carrying the endosome-targeting V-domain; endogenous GADS has not been shown to act on endosomes. Kept as a non-core, partner-dependent location.
Supporting Evidence:
PMID:21179510
led to the relocation of most of the cytosolic Grb2 and GrpL to endosomes
GO:0005829 cytosol
IDA
GO_REF:0000052
ACCEPT
Summary: IDA cytosol (GO_REF:0000052).
Reason: GADS is a cytosolic adaptor; Reactome places the GADS:SLP-76 complex in the cytosol before its recruitment to phospho-LAT.
Supporting Evidence:
PMID:21179510
the rest was dispersed throughout the cytosol and in the nucleus
GO:0005829 cytosol
IEA
GO_REF:0000117
ACCEPT
Summary: IEA cytosol (GO_REF:0000117).
Reason: GADS is a cytosolic adaptor; Reactome places the GADS:SLP-76 complex in the cytosol before its recruitment to phospho-LAT.
Supporting Evidence:
PMID:21179510
the rest was dispersed throughout the cytosol and in the nucleus
GO:0005829 cytosol
TAS
Reactome:R-HSA-1433501
ACCEPT
Summary: TAS cytosol (Reactome:R-HSA-1433501).
Reason: GADS is a cytosolic adaptor; Reactome places the GADS:SLP-76 complex in the cytosol before its recruitment to phospho-LAT.
GO:0005829 cytosol
TAS
Reactome:R-HSA-202216
ACCEPT
Summary: TAS cytosol (Reactome:R-HSA-202216).
Reason: GADS is a cytosolic adaptor; Reactome places the GADS:SLP-76 complex in the cytosol before its recruitment to phospho-LAT.
GO:0005829 cytosol
TAS
Reactome:R-HSA-202241
ACCEPT
Summary: TAS cytosol (Reactome:R-HSA-202241).
Reason: GADS is a cytosolic adaptor; Reactome places the GADS:SLP-76 complex in the cytosol before its recruitment to phospho-LAT.
GO:0005829 cytosol
TAS
Reactome:R-HSA-202248
ACCEPT
Summary: TAS cytosol (Reactome:R-HSA-202248).
Reason: GADS is a cytosolic adaptor; Reactome places the GADS:SLP-76 complex in the cytosol before its recruitment to phospho-LAT.
GO:0005829 cytosol
TAS
Reactome:R-HSA-202325
ACCEPT
Summary: TAS cytosol (Reactome:R-HSA-202325).
Reason: GADS is a cytosolic adaptor; Reactome places the GADS:SLP-76 complex in the cytosol before its recruitment to phospho-LAT.
GO:0005829 cytosol
TAS
Reactome:R-HSA-202331
ACCEPT
Summary: TAS cytosol (Reactome:R-HSA-202331).
Reason: GADS is a cytosolic adaptor; Reactome places the GADS:SLP-76 complex in the cytosol before its recruitment to phospho-LAT.
GO:0005829 cytosol
TAS
Reactome:R-HSA-202375
ACCEPT
Summary: TAS cytosol (Reactome:R-HSA-202375).
Reason: GADS is a cytosolic adaptor; Reactome places the GADS:SLP-76 complex in the cytosol before its recruitment to phospho-LAT.
GO:0005829 cytosol
TAS
Reactome:R-HSA-213407
ACCEPT
Summary: TAS cytosol (Reactome:R-HSA-213407).
Reason: GADS is a cytosolic adaptor; Reactome places the GADS:SLP-76 complex in the cytosol before its recruitment to phospho-LAT.
GO:0005829 cytosol
TAS
Reactome:R-HSA-2396561
ACCEPT
Summary: TAS cytosol (Reactome:R-HSA-2396561).
Reason: GADS is a cytosolic adaptor; Reactome places the GADS:SLP-76 complex in the cytosol before its recruitment to phospho-LAT.
GO:0005829 cytosol
TAS
Reactome:R-HSA-2396594
ACCEPT
Summary: TAS cytosol (Reactome:R-HSA-2396594).
Reason: GADS is a cytosolic adaptor; Reactome places the GADS:SLP-76 complex in the cytosol before its recruitment to phospho-LAT.
GO:0005829 cytosol
TAS
Reactome:R-HSA-2396606
ACCEPT
Summary: TAS cytosol (Reactome:R-HSA-2396606).
Reason: GADS is a cytosolic adaptor; Reactome places the GADS:SLP-76 complex in the cytosol before its recruitment to phospho-LAT.
GO:0005829 cytosol
TAS
Reactome:R-HSA-2424476
ACCEPT
Summary: TAS cytosol (Reactome:R-HSA-2424476).
Reason: GADS is a cytosolic adaptor; Reactome places the GADS:SLP-76 complex in the cytosol before its recruitment to phospho-LAT.
GO:0005829 cytosol
TAS
Reactome:R-HSA-2424481
ACCEPT
Summary: TAS cytosol (Reactome:R-HSA-2424481).
Reason: GADS is a cytosolic adaptor; Reactome places the GADS:SLP-76 complex in the cytosol before its recruitment to phospho-LAT.
GO:0005829 cytosol
TAS
Reactome:R-HSA-2424484
ACCEPT
Summary: TAS cytosol (Reactome:R-HSA-2424484).
Reason: GADS is a cytosolic adaptor; Reactome places the GADS:SLP-76 complex in the cytosol before its recruitment to phospho-LAT.
GO:0005829 cytosol
TAS
Reactome:R-HSA-2424485
ACCEPT
Summary: TAS cytosol (Reactome:R-HSA-2424485).
Reason: GADS is a cytosolic adaptor; Reactome places the GADS:SLP-76 complex in the cytosol before its recruitment to phospho-LAT.
GO:0005829 cytosol
TAS
Reactome:R-HSA-2424486
ACCEPT
Summary: TAS cytosol (Reactome:R-HSA-2424486).
Reason: GADS is a cytosolic adaptor; Reactome places the GADS:SLP-76 complex in the cytosol before its recruitment to phospho-LAT.
GO:0005829 cytosol
TAS
Reactome:R-HSA-2424487
ACCEPT
Summary: TAS cytosol (Reactome:R-HSA-2424487).
Reason: GADS is a cytosolic adaptor; Reactome places the GADS:SLP-76 complex in the cytosol before its recruitment to phospho-LAT.
GO:0005829 cytosol
TAS
Reactome:R-HSA-2730833
ACCEPT
Summary: TAS cytosol (Reactome:R-HSA-2730833).
Reason: GADS is a cytosolic adaptor; Reactome places the GADS:SLP-76 complex in the cytosol before its recruitment to phospho-LAT.
GO:0005829 cytosol
TAS
Reactome:R-HSA-2730840
ACCEPT
Summary: TAS cytosol (Reactome:R-HSA-2730840).
Reason: GADS is a cytosolic adaptor; Reactome places the GADS:SLP-76 complex in the cytosol before its recruitment to phospho-LAT.
GO:0005829 cytosol
TAS
Reactome:R-HSA-2730841
ACCEPT
Summary: TAS cytosol (Reactome:R-HSA-2730841).
Reason: GADS is a cytosolic adaptor; Reactome places the GADS:SLP-76 complex in the cytosol before its recruitment to phospho-LAT.
GO:0005829 cytosol
TAS
Reactome:R-HSA-2730847
ACCEPT
Summary: TAS cytosol (Reactome:R-HSA-2730847).
Reason: GADS is a cytosolic adaptor; Reactome places the GADS:SLP-76 complex in the cytosol before its recruitment to phospho-LAT.
GO:0005829 cytosol
TAS
Reactome:R-HSA-2730851
ACCEPT
Summary: TAS cytosol (Reactome:R-HSA-2730851).
Reason: GADS is a cytosolic adaptor; Reactome places the GADS:SLP-76 complex in the cytosol before its recruitment to phospho-LAT.
GO:0005829 cytosol
TAS
Reactome:R-HSA-2730856
ACCEPT
Summary: TAS cytosol (Reactome:R-HSA-2730856).
Reason: GADS is a cytosolic adaptor; Reactome places the GADS:SLP-76 complex in the cytosol before its recruitment to phospho-LAT.
GO:0005829 cytosol
TAS
Reactome:R-HSA-2730858
ACCEPT
Summary: TAS cytosol (Reactome:R-HSA-2730858).
Reason: GADS is a cytosolic adaptor; Reactome places the GADS:SLP-76 complex in the cytosol before its recruitment to phospho-LAT.
GO:0005829 cytosol
TAS
Reactome:R-HSA-2730889
ACCEPT
Summary: TAS cytosol (Reactome:R-HSA-2730889).
Reason: GADS is a cytosolic adaptor; Reactome places the GADS:SLP-76 complex in the cytosol before its recruitment to phospho-LAT.
GO:0005829 cytosol
TAS
Reactome:R-HSA-2730892
ACCEPT
Summary: TAS cytosol (Reactome:R-HSA-2730892).
Reason: GADS is a cytosolic adaptor; Reactome places the GADS:SLP-76 complex in the cytosol before its recruitment to phospho-LAT.
GO:0005829 cytosol
TAS
Reactome:R-HSA-389381
ACCEPT
Summary: TAS cytosol (Reactome:R-HSA-389381).
Reason: GADS is a cytosolic adaptor; Reactome places the GADS:SLP-76 complex in the cytosol before its recruitment to phospho-LAT.
GO:0005829 cytosol
TAS
Reactome:R-HSA-9706304
ACCEPT
Summary: TAS cytosol (Reactome:R-HSA-9706304).
Reason: GADS is a cytosolic adaptor; Reactome places the GADS:SLP-76 complex in the cytosol before its recruitment to phospho-LAT.
GO:0005886 plasma membrane
IBA
GO_REF:0000033
ACCEPT
Summary: IBA is_active_in plasma membrane (GRB2-family node).
Reason: GADS exercises its adaptor activity at the plasma membrane, where its SH2 domain docks on phospho-LAT and brings SLP-76 into LAT microclusters.
Supporting Evidence:
PMID:10021361
Gads may promote cross-talk between the LAT and SLP-76 signaling complexes, thereby coupling membrane-proximal events to downstream signaling pathways
GO:0007165 signal transduction
IBA
GO_REF:0000033
ACCEPT
Summary: IBA signal transduction.
Reason: Correct general parent of the antigen-receptor signaling pathways in which GADS acts as an adaptor; the specific pathways are proposed below.
Supporting Evidence:
PMID:10021361
Gads may promote cross-talk between the LAT and SLP-76 signaling complexes, thereby coupling membrane-proximal events to downstream signaling pathways
GO:0007265 Ras protein signal transduction
TAS
PMID:9878555
Molecular cloning and expression of human grap-2, a novel le...
MARK AS OVER ANNOTATED
Summary: TAS Ras protein signal transduction (PMID:9878555).
Reason: Unlike GRB2, GADS does not bind SOS; its SH3 domains select SLP-76 and HPK1, and it couples tyrosine-phosphorylated proteins to effectors distinct from SOS and Ras. The cloning paper only speculates about receptor tyrosine kinase signaling. Any effect on Ras/ERK in T cells is indirect, via SLP-76/PLCG1.
Supporting Evidence:
PMID:9872323
Gads may function to couple tyrosine-phosphorylated proteins such as Shc, Bcr-Abl and activated receptor tyrosine kinases to downstream effectors distinct from Sos and Ras
PMID:10209041
GrpL can be coimmunoprecipitated with SLP-76 but not with Sos1 or Sos2
GO:0007267 cell-cell signaling
TAS
PMID:9878555
Molecular cloning and expression of human grap-2, a novel le...
MARK AS OVER ANNOTATED
Summary: TAS cell-cell signaling (PMID:9878555).
Reason: GADS is an intracellular adaptor acting within receptor signaling in the responding cell; the cloning paper does not support a role in cell-cell signaling as such, and the informative process is the specific receptor signaling pathway (T cell receptor signaling pathway, proposed as NEW).
Supporting Evidence:
PMID:9878555
Grap-2 may participate in leukocyte-specific protein tyrosine kinase signaling
GO:0043408 regulation of MAPK cascade
IBA
GO_REF:0000033
KEEP AS NON CORE
Summary: IBA regulation of MAPK cascade (GRB2-family node).
Reason: Inherited from GRB2-family adaptors. For GADS there is supporting evidence that it promotes HPK1-mediated JNK activation and prolonged MAPK activation after M-CSF stimulation in myeloid progenitors, but these are secondary to its adaptor role in antigen-receptor signaling.
Supporting Evidence:
PMID:11313918
Coexpression of Grap2 with HPK1 not only increased the kinase activity of HPK1 in the cell, but also had an additive effect on HPK1 mediated JNK activation
GO:0050852 T cell receptor signaling pathway
IMP
PMID:25452106
Modulation of TCR responsiveness by the Grb2-family adaptor,...
NEW
Summary: Proposed NEW: GADS is the adaptor that bridges SLP-76 to phospho-LAT in TCR signaling.
Reason: Participation test: GADS does part of the work of the pathway, physically linking the SLP-76 scaffold (via its C-SH3/RxxK interaction) to ZAP70-phosphorylated LAT (via its SH2), which assembles the PLCG1-activating signalosome. Comparator check: LAT and LCP2, the other two adaptors of the same trimeric complex, carry this term (reviews in this repository). Evidence: Gads-deficient thymocytes uncouple SLP-76 from LAT and fail to respond to CD3 cross-linking; Gads-deficient Jurkat cells lose sensitivity to weak TCR stimuli. No GOA row currently places GRAP2 in this pathway. Human loss-of-function data agree: GADS-suppressed HuT78 CD4+ T cells show reduced recruitment of SLP-76 and PLCG1 to LAT, calcium flux and cytokine release (PMID:25636200), while GADS-knockout Jurkat cells show network rewiring with largely preserved proximal events but reduced activation and cytokine secretion (PMID:37006259).
Supporting Evidence:
PMID:25452106
Gads conferred responsiveness to weak TCR stimuli, leading to PLC-Ξ³1 phosphorylation and calcium flux
PMID:11239162
Immunoprecipitation experiments revealed that the association between SLP-76 and LAT was uncoupled in GADS- thymocytes
PMID:11239162
These observations indicate that GADS is a critical adaptor for CD3 signaling
PMID:17235283
Gads, on the other hand, links phosphorylated LAT to the scaffold protein, SLP-76, which binds the Gads C-SH3 domain
PMID:25636200
The defect in cytokine production occurred because of impaired calcium mobilization due to reduced recruitment of SLP-76 and PLC-Ξ³1 to the LAT complex
GO:0038095 Fc-epsilon receptor signaling pathway
IMP
PMID:18664516
Selective impairment of FcepsilonRI-mediated allergic reacti...
NEW
Summary: Proposed NEW: GADS acts as the LAT-SLP-76 bridging adaptor downstream of FcERI in mast cells.
Reason: Participation test: in mast cells GADS performs the same bridging adaptor work as in T cells, recruiting SLP-76 to phospho-LAT after FcERI cross-linking. Comparator check: LAT and LCP2 carry this term (reviews in this repository). Evidence: Gads-/- bone marrow-derived mast cells fail to mobilize calcium, degranulate or produce cytokines after FcERI cross-linking, and passive cutaneous anaphylaxis is impaired; disrupting the SLP-76/Gads interaction blocks SLP-76 clustering and FcERI responses.
Supporting Evidence:
PMID:18664516
Bone marrow-derived mast cells from Gads(-/-) mice failed to induce Ca(2+) mobilization, degranulation and cytokine production upon cross-linking of FcepsilonRI
PMID:16479002
the Gads-binding region of SLP-76 regulates clustering of SLP-76 and FcepsilonRI-induced mast cell responses
GO:0036398 TCR signalosome
IDA
PMID:10021361
The hematopoietic-specific adaptor protein gads functions in...
NEW
Summary: Proposed NEW: GADS is a component of the LAT-GADS-SLP-76 TCR signalosome.
Reason: GADS is one of the three adaptors of the heterotrimeric LAT-GADS-SLP-76 complex nucleated on phospho-LAT after TCR engagement; it co-immunoprecipitates phospho-LAT after TCR cross-linking via its SH2 domain while constitutively holding SLP-76. LAT and LCP2 are annotated part_of this complex.
Supporting Evidence:
PMID:10021361
Gads also coimmunoprecipitated the tyrosine-phosphorylated form of the linker for activated T cells (LAT) adaptor protein following cross-linking of the T-cell receptor
PMID:31402911
Three adaptors, LAT, Gads, and SLP-76, form a heterotrimeric complex that mediates signaling by the T cell antigen receptor (TCR) and by the mast cell high affinity receptor for IgE (FcΞ΅RI)

Core Functions

Bridging adaptor of the TCR signalosome: the C-terminal SH3 domain holds SLP-76 (LCP2) through its RxxK motif and the SH2 domain docks on phospho-LAT, recruiting SLP-76 to LAT microclusters at the plasma membrane and coupling TCR engagement to PLCG1 activation, calcium flux and NFAT activation.

Supporting Evidence:
  • PMID:17235283
    In signaling from the T-cell receptor (TCR), the Gads C-terminal SH3 domain binds a core RxxK sequence motif in the SLP-76 scaffold
  • PMID:15029250
    Gads-SH2 binds LAT tyrosine phosphorylation sites 171 and 191 with higher affinities than the other sites
  • PMID:11239162
    Immunoprecipitation experiments revealed that the association between SLP-76 and LAT was uncoupled in GADS- thymocytes
  • PMID:25452106
    Gads conferred responsiveness to weak TCR stimuli, leading to PLC-Ξ³1 phosphorylation and calcium flux
  • PMID:10021361
    Gads may promote cross-talk between the LAT and SLP-76 signaling complexes, thereby coupling membrane-proximal events to downstream signaling pathways
  • PMID:25636200
    The defect in cytokine production occurred because of impaired calcium mobilization due to reduced recruitment of SLP-76 and PLC-Ξ³1 to the LAT complex
  • PMID:37006259
    our analysis showed that 100% of the SLP76 molecules are constitutively associated with GADS
  • PMID:30510001
    The K d for SLP-76 FL /Gads FL binding was 9 nM
  • file:human/GRAP2/GRAP2-deep-research-falcon.md
    GRAP2 does not catalyze phosphorylation, phospholipid hydrolysis or transport

The same LAT-SLP-76 bridging adaptor function downstream of FcERI in mast cells, required for calcium mobilization, degranulation and cytokine production.

Molecular Function:
signaling adaptor activity
Cellular Locations:
Supporting Evidence:
  • PMID:18664516
    Bone marrow-derived mast cells from Gads(-/-) mice failed to induce Ca(2+) mobilization, degranulation and cytokine production upon cross-linking of FcepsilonRI
  • PMID:31402911
    Three adaptors, LAT, Gads, and SLP-76, form a heterotrimeric complex that mediates signaling by the T cell antigen receptor (TCR) and by the mast cell high affinity receptor for IgE (FcΞ΅RI)

References

Loading supporting content…

Download this section (compressed HTML)

Suggested Questions for Experts

Q: Should GRAP2 carry collagen-activated signaling pathway (GPVI) and CLEC-2 signaling terms, given that Gads is needed only for responses to weak GPVI/CLEC-2 stimulation and is largely redundant with GRB2 in platelets (PMID:18826392, PMID:31948362)?

Q: Several reports (PMID:9857184, PMID:11034310) place Mona/GADS downstream of the M-CSF receptor in monocyte/macrophage development; is there loss-of-function evidence that would justify a myeloid receptor signaling term in addition to the antigen-receptor pathways?

Q: GOA has no T cell receptor signaling pathway annotation for GRAP2 despite the knockout and Jurkat-knockout data; are the NEW TCR signaling, FcERI signaling and TCR signalosome rows acceptable to GO curators?

Q: Early work reported that phospho-LAT associates with Grb2 but not GrpL (PMID:10209041), whereas later studies consistently show SH2-dependent GADS binding to LAT pY171/pY191; is the early negative result explained by lysis conditions or antibody choice?

Q: GADS binds FLT3 pY955/pY969 and potentiates FLT3-ITD mitogenic signaling in engineered cells and xenografts (PMID:26895103); is there evidence from primary myeloid cells or AML samples that would justify a FLT3 signaling annotation, or is this restricted to overexpression systems?

Q: GADS-knockout Jurkat cells preserve early PLCG1 phosphorylation and calcium flux (PMID:37006259) whereas GADS-suppressed HuT78 cells lose calcium flux (PMID:25636200); which compensating adaptors (GRB2, CD6-associated complexes) explain the difference, and which model reflects primary human T cells?

Suggested Experiments

Experiment: In GADS-knockout Jurkat or primary human T cells, reconstitute wild-type GADS, a dimerization-defective mutant, Y45F and T262A, and measure LAT-SLP-76 coupling, PLCG1 phosphorylation, calcium flux and CD69 induction across a titration of TCR stimulus strength.

Hypothesis: GADS dimerization and linker/N-SH3 phosphorylation set the TCR stimulus threshold by controlling cooperative binding of GADS to multiple LAT phosphotyrosines.

Type: genetic complementation with domain mutants

Experiment: Use proximity labelling (TurboID-GADS) in resting and TCR- or FcERI-stimulated cells to identify GADS partners other than SLP-76 and LAT, comparing wild-type and SH2 (R-to-K) or C-SH3 mutants.

Hypothesis: GADS has partners beyond SLP-76 and LAT (e.g. HPK1, CD6) that contribute to branch-specific signaling and to its distinct phenotype compared with SLP-76 or LAT loss.

Type: proximity proteomics

Deep Research

Falcon

(GRAP2-deep-research-falcon.md)

Loading supporting content…

Download this section (compressed HTML)

πŸ“š Additional Documentation

Notes

(GRAP2-notes.md)

Loading supporting content…

Download this section (compressed HTML)

πŸ“„ View Raw YAML

Loading supporting content…

Download this section (compressed HTML)